SPEAKING AT:
Carlos María Galmarini, MD, PhD, is the founder of Topazium. He trained in clinical oncology in Argentina and completed post‑doctoral fellowships at the City of Hope Cancer Center (USA) and the Léon Bérard Cancer Center (France), where he also obtained his PhD and HDR. He has held clinical and research positions in Buenos Aires and Lyon, and later served as Head of Cell Biology and Pharmacogenomics at PharmaMar (Spain). Author of more than 130 scientific publications. With more than 10 years of experience applying AI to healthcare, he mainly focuses on digital diagnostics, predictive modeling, and the development of advanced tools for medical decision support.